In September 2026, the journal Nature published the largest to date atlas of gene expression in the human dorsolateral prefrontal cortex — data on 6,3 million cells from 1494 donors of different ages and health statuses. The study by the PsychAD consortium does not merely record changes: it shows that gene activity in this key region of the brain unfolds in three distinct acts, each of which carries its own risks for cognitive and emotional functions.
The first act is early development. From infancy to approximately 24 years, large-scale rearrangements occur: neurons actively rewire connections, forming the foundation for planning, emotional control, and decision-making. The second act is the relative stability of maturity, when gene expression levels out and the brain operates at maximum efficiency. The third act begins after 65 years: cells reprogram, glial and immune elements are activated, and neurons become more vulnerable. This nonlinear picture explains why many mental disorders manifest precisely during certain periods of life.
It is especially noteworthy that diseases — from Alzheimer's and Parkinson's to schizophrenia and bipolar disorder — share common molecular pathways linked to basic cellular functions, but converge most strongly in disruptions of neuronal development and synaptic transmission. This indicates that different diagnoses may exploit the same "weak spots" of the prefrontal cortex, which arose in the early years or became activated in old age.
Genetic risk also manifests in a cell-specific manner: disease-associated variants affect certain cell types differently in people of European, African, and American genetic ancestry. Such an approach dismantles simplified notions of "disease genes" and shows how individual vulnerability is formed at the intersection of heredity, age, and cellular context.
Imagine the prefrontal cortex as a theater where genes are the actors. In the first act they rehearse complex roles, in the second they confidently hold the stage, in the third they begin to falter and require support from supporting characters. When that support weakens, the performance falls apart — whether it is a loss of concentration in old age or a flare-up of symptoms of a mental disorder.
This atlas provides not only data but also a tool: an open resource that will make it possible to track more precisely where exactly in the cellular mosaic of the brain deviations begin, and to develop interventions targeting specific stages of life and cell types. Ultimately, it reminds us that mental health is not a static state but a dynamic process that depends on how harmoniously the genes play at each stage of human life.
